je.st
news
FDA Approves Expanded Age Indication for GARDASIL 9 in Males
2015-12-15 23:07:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. GARDASIL 9 Now Approved for Males 16 through 26 Years of Age for the Prevention of Anal Cancers and Genital Warts Caused by Nine HPV types KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orDeb Wambold, 215-652-2913orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Media Capsule: Please Activate Javascript !function(d, s, id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https',dt=new Date().getTime();if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://s3.amazonaws.com/contentcapsule.com/clients/Merck/tags/4ef0f659-dc5f-471f-a926-02d1aa18adfe_reg_frame.js?dt="+dt;fjs.parentNode.insertBefore(js,fjs);}}(document,"script","contentcapsule-embed-4ef0f659-dc5f-471f-a926-02d1aa18adfe"); read more
Tags: in
age
expanded
indication
Category:Biotechnology and Pharmaceuticals